NM_000528.4:c.*105C>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000528.4(MAN2B1):​c.*105C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000999 in 871,058 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00081 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0010 ( 4 hom. )

Consequence

MAN2B1
NM_000528.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.788

Publications

1 publications found
Variant links:
Genes affected
MAN2B1 (HGNC:6826): (mannosidase alpha class 2B member 1) This gene encodes an enzyme that hydrolyzes terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. Its activity is necessary for the catabolism of N-linked carbohydrates released during glycoprotein turnover and it is member of family 38 of glycosyl hydrolases. The full length protein is processed in two steps. First, a 49 aa leader sequence is cleaved off and the remainder of the protein is processed into 3 peptides of 70 kDa, 42 kDa (D) and 13/15 kDa (E). Next, the 70 kDa peptide is further processed into three peptides (A, B and C). The A, B and C peptides are disulfide-linked. Defects in this gene have been associated with lysosomal alpha-mannosidosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
MAN2B1 Gene-Disease associations (from GenCC):
  • alpha-mannosidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Laboratory for Molecular Medicine, Myriad Women’s Health, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000528.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAN2B1
NM_000528.4
MANE Select
c.*105C>G
3_prime_UTR
Exon 24 of 24NP_000519.2O00754-1
MAN2B1
NM_001440570.1
c.*105C>G
3_prime_UTR
Exon 24 of 24NP_001427499.1
MAN2B1
NM_001173498.2
c.*105C>G
3_prime_UTR
Exon 24 of 24NP_001166969.1O00754-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAN2B1
ENST00000456935.7
TSL:1 MANE Select
c.*105C>G
3_prime_UTR
Exon 24 of 24ENSP00000395473.2O00754-1
MAN2B1
ENST00000221363.9
TSL:1
c.*105C>G
3_prime_UTR
Exon 24 of 24ENSP00000221363.4O00754-2
ENSG00000269242
ENST00000597692.1
TSL:2
n.*105C>G
non_coding_transcript_exon
Exon 4 of 5ENSP00000470240.1M0QZ24

Frequencies

GnomAD3 genomes
AF:
0.000815
AC:
124
AN:
152140
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000764
Gnomad OTH
AF:
0.000478
GnomAD4 exome
AF:
0.00104
AC:
747
AN:
718800
Hom.:
4
Cov.:
9
AF XY:
0.00101
AC XY:
384
AN XY:
380434
show subpopulations
African (AFR)
AF:
0.000105
AC:
2
AN:
19022
American (AMR)
AF:
0.000136
AC:
5
AN:
36642
Ashkenazi Jewish (ASJ)
AF:
0.000143
AC:
3
AN:
20950
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34738
South Asian (SAS)
AF:
0.00103
AC:
70
AN:
68266
European-Finnish (FIN)
AF:
0.00478
AC:
239
AN:
50046
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4358
European-Non Finnish (NFE)
AF:
0.000889
AC:
399
AN:
448878
Other (OTH)
AF:
0.000808
AC:
29
AN:
35900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000808
AC:
123
AN:
152258
Hom.:
0
Cov.:
31
AF XY:
0.000967
AC XY:
72
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41540
American (AMR)
AF:
0.000131
AC:
2
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.00565
AC:
60
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000764
AC:
52
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000424
Hom.:
0
Bravo
AF:
0.000506
Asia WGS
AF:
0.000866
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Deficiency of alpha-mannosidase (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.0
DANN
Benign
0.58
PhyloP100
-0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs547349667; hg19: chr19-12757329; API